Maurizio Recanatini
Maurizio Recanatini
Retired Professor of Medicinal Chemistry, University of Bologna
Verified email at
Cited by
Cited by
Multi-target-directed ligands to combat neurodegenerative diseases
A Cavalli, ML Bolognesi, A Minarini, M Rosini, V Tumiatti, M Recanatini, ...
Journal of medicinal chemistry 51 (3), 347-372, 2008
Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K+ channel blockers
A Cavalli, E Poluzzi, F De Ponti, M Recanatini
Journal of medicinal chemistry 45 (18), 3844-3853, 2002
Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview
F De Ponti, E Poluzzi, A Cavalli, M Recanatini, N Montanaro
Drug safety 25, 263-286, 2002
QT prolongation through hERG K+ channel blockade: Current knowledge and strategies for the early prediction during drug development
M Recanatini, E Poluzzi, M Masetti, A Cavalli, F De Ponti
Medicinal research reviews 25 (2), 133-166, 2005
3-(4-{[Benzyl(methyl)amino]methyl}phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) Inhibits Both Acetylcholinesterase and Acetylcholinesterase-Induced β …
L Piazzi, A Rampa, A Bisi, S Gobbi, F Belluti, A Cavalli, M Bartolini, ...
Journal of medicinal chemistry 46 (12), 2279-2282, 2003
Multi-target-directed drug design strategy: from a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against Alzheimer’s disease
ML Bolognesi, A Cavalli, L Valgimigli, M Bartolini, M Rosini, V Andrisano, ...
Journal of medicinal chemistry 50 (26), 6446-6449, 2007
Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds
L Piazzi, A Cavalli, F Colizzi, F Belluti, M Bartolini, F Mancini, ...
Bioorganic & Medicinal Chemistry Letters 18 (1), 423-426, 2008
A small molecule targeting the multifactorial nature of Alzheimer's disease
A Cavalli, ML Bolognesi, S Capsoni, V Andrisano, M Bartolini, E Margotti, ...
SAR of 9-amino-1, 2, 3, 4-tetrahydroacridine-based acetylcholinesterase inhibitors: synthesis, enzyme inhibitory activity, QSAR, and structure-based CoMFA of tacrine analogues
M Recanatini, A Cavalli, F Belluti, L Piazzi, A Rampa, A Bisi, S Gobbi, ...
Journal of medicinal chemistry 43 (10), 2007-2018, 2000
Single-molecule pulling simulations can discern active from inactive enzyme inhibitors
F Colizzi, R Perozzo, L Scapozza, M Recanatini, A Cavalli
Journal of the American Chemical Society 132 (21), 7361-7371, 2010
Galloflavin (CAS 568‐80‐9): a novel inhibitor of lactate dehydrogenase
M Manerba, M Vettraino, L Fiume, G Di Stefano, A Sartini, E Giacomini, ...
ChemMedChem 7 (2), 311-317, 2012
Phytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspective
E Poluzzi, C Piccinni, E Raschi, A Rampa, M Recanatini, F De Ponti
Current medicinal chemistry 21 (4), 417-436, 2014
A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17α-hydroxylase/C17 …
M Recanatini, A Bisi, A Cavalli, F Belluti, S Gobbi, A Rampa, P Valenti, ...
Journal of medicinal chemistry 44 (5), 672-680, 2001
Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's disease
ML Bolognesi, R Banzi, M Bartolini, A Cavalli, A Tarozzi, V Andrisano, ...
Journal of medicinal chemistry 50 (20), 4882-4897, 2007
Determination of lipophilicity by means of reversed-phase thin-layer chromatography: I. Basic aspects and relationship between slope and intercept of TLC equations
GL Biagi, AM Barbaro, A Sapone, M Recanatini
Journal of Chromatography A 662 (2), 341-361, 1994
Dynamic docking: a paradigm shift in computational drug discovery
D Gioia, M Bertazzo, M Recanatini, M Masetti, A Cavalli
Molecules 22 (11), 2029, 2017
Protein conformational transitions: the closure mechanism of a kinase explored by atomistic simulations
A Berteotti, A Cavalli, D Branduardi, FL Gervasio, M Recanatini, ...
Journal of the American Chemical Society 131 (1), 244-250, 2009
The role of fragment-based and computational methods in polypharmacology
G Bottegoni, AD Favia, M Recanatini, A Cavalli
Drug discovery today 17 (1-2), 23-34, 2012
Target-related applications of first principles quantum chemical methods in drug design
A Cavalli, P Carloni, M Recanatini
Chemical reviews 106 (9), 3497-3519, 2006
The role of the peripheral anionic site and cation− π interactions in the ligand penetration of the human AChE gorge
D Branduardi, FL Gervasio, A Cavalli, M Recanatini, M Parrinello
Journal of the American Chemical Society 127 (25), 9147-9155, 2005
The system can't perform the operation now. Try again later.
Articles 1–20